Page last updated: 2024-10-20

pyrazole and Toxoplasmosis, Cerebral

pyrazole has been researched along with Toxoplasmosis, Cerebral in 1 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Toxoplasmosis, Cerebral: Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rutaganira, FU1
Barks, J1
Dhason, MS1
Wang, Q1
Lopez, MS1
Long, S1
Radke, JB1
Jones, NG1
Maddirala, AR1
Janetka, JW1
El Bakkouri, M1
Hui, R1
Shokat, KM1
Sibley, LD1

Other Studies

1 other study available for pyrazole and Toxoplasmosis, Cerebral

ArticleYear
Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
    Journal of medicinal chemistry, 2017, 12-28, Volume: 60, Issue:24

    Topics: Animals; Antiprotozoal Agents; Female; Humans; Male; Mice; Protein Kinase Inhibitors; Protein Kinase

2017